1. Home
  2. TRIB vs ACXP Comparison

TRIB vs ACXP Comparison

Compare TRIB & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Biotech plc

TRIB

Trinity Biotech plc

N/A

Current Price

$5.49

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

N/A

Current Price

$1.05

Market Cap

5.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIB
ACXP
Founded
1992
2017
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
TRIB
ACXP
Price
$5.49
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
9.1K
★ 94.2K
Earning Date
12-22-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.89
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.90
52 Week High
$14.17
$7.54

Technical Indicators

Market Signals
Indicator
TRIB
ACXP
Relative Strength Index (RSI) 40.72 46.16
Support Level $5.01 $0.95
Resistance Level $7.45 $1.12
Average True Range (ATR) 0.58 0.09
MACD -0.03 0.01
Stochastic Oscillator 26.22 62.81

Price Performance

Historical Comparison
TRIB
ACXP

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: